Vivacelle Bio, Inc. — Form D/A

Vivacelle Bio, Inc. of Evanston, IL, a company, filed a Form D amendment with the SEC on 2016-09-09. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Ron Ormand DamperDirectorChicago, IL
Harven Ormand DeShieldDirectorChicago, IL
Stephen Ormand KeithDirectorChicago, IL
Cuthbert Ormand SimpkinsDirectorChicago, IL
Diane Ormand SimpkinsDirectorChicago, IL
Harven Ormand DeShieldExecutive OfficerChicago, IL
Stephen Ormand KeithExecutive OfficerChicago, IL
Cuthbert Ormand SimpkinsExecutive OfficerChicago, IL
Diane Ormand SimpkinsExecutive OfficerChicago, IL
Stephen KeithDirectorToronto, A6
Stephen KeithExecutive OfficerToronto, A6
Paul BurtonDirectorChicago, IL
Paul BurtonExecutive OfficerChicago, IL
Cuthbert SimpkinsDirectorEvanston, IL
Cuthbert SimpkinsExecutive OfficerEvanston, IL
Ron DamperDirectorEvanston, IL
Diane SimpkinsDirectorEvanston, IL
Diane SimpkinsExecutive OfficerEvanston, IL
Krishna TalluriDirectorEvanston, IL
Krishna TalluriExecutive OfficerEvanston, IL
Harven DeShieldDirectorEvanston, IL
Harven DeShieldExecutive OfficerEvanston, IL
Edward NicholsExecutive OfficerShreveport, LA

Other filings by this issuer (5)

FiledFormOfferingSold
2019-02-11D/A$3.4M$2.9M
2018-03-13D/A$1.5M$514K
2016-08-17D$1.5M$100K
2014-08-08D/A$550K$550K
2014-02-13D$1.0M$225K

More